West Virginia to receive $22.5M from Lilly in Zyprexa suit

Eli Lilly and Co. agreed to pay West Virginia $22.5 million to end litigation on alleged improper marketing of antipsychotic drug Zyprexa. The settlement is part of Lilly's $1.42 billion deal with the Justice Department to resolve a marketing investigation.

View Full Article in:

Indianapolis Star (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC